0001787640 false 0001787640 2022-06-01 2022-06-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

  

UNITED STATES 

SECURITIES AND EXCHANGE COMMISSION 

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT 

PURSUANT TO SECTION 13 OR 15(d) 

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): June 1, 2022

 

 

 

Convey Health Solutions Holdings, Inc.

(Exact name of registrant as specified in its charter)

 

 

Delaware 001-40506 84-2099378

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

 

100 SE 3rd Avenue, 26th Floor, Fort Lauderdale, Florida 33394

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (800) 559-9358

 

Not applicable 

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)  

Name of each exchange
on which registered

Common Stock, $0.01 par value per share   CNVY   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders.

 

(a) On June 1, 2022, Convey Health Solutions Holdings, Inc. (the “Company”) held its 2022 annual meeting of stockholders (the “2022 Annual Meeting”) at which stockholders voted to (i) elect two Class I directors to hold office until the 2025 annual meeting of stockholders and (ii) ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. With respect to the proposals below, any abstentions, withhold votes and broker non-votes were considered “shares present” for purposes of establishing a quorum but were not considered votes properly cast at the 2022 Annual Meeting and therefore had no effect on the outcome of the vote.

 

(b) The final results of the matters voted on at the 2022 Annual Meeting are set forth below.

 

Proposal No. 1 – Election of Class I directors:

 

Nominee  For   Withheld   Broker Non-Votes 
Sharad S. Mansukani  60,743,339   3,165,741   3,093,089 
Katherine Wood  60,746,089   3,162,991   3,093,089 

 

Each Class I director was elected to hold office until the 2025 annual meeting of stockholders.

 

Proposal No. 2 – Ratification of the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022:

 

For   Against   Abstain   Broker Non-Votes 
66,818,717   180,359   3,093   0 

 

This proposal was approved.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CONVEY HEALTH SOLUTIONS HOLDINGS, INC.
   
   
Date: June 6, 2022 By: /s/ Timothy Fairbanks
  Name: Timothy Fairbanks
  Title: Chief Financial Officer & Executive Vice President

 

 

 

Convey Health Solutions (NYSE:CNVY)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025 Convey Health Solutions 차트를 더 보려면 여기를 클릭.
Convey Health Solutions (NYSE:CNVY)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025 Convey Health Solutions 차트를 더 보려면 여기를 클릭.